The store will not work correctly when cookies are disabled.
methyl 4-prop-2-enoyl-2,3-dihydroquinoxaline-1-carboxylate
ID: ALA4578788
PubChem CID: 155564804
Max Phase: Preclinical
Molecular Formula: C13H14N2O3
Molecular Weight: 246.27
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: C=CC(=O)N1CCN(C(=O)OC)c2ccccc21
Standard InChI: InChI=1S/C13H14N2O3/c1-3-12(16)14-8-9-15(13(17)18-2)11-7-5-4-6-10(11)14/h3-7H,1,8-9H2,2H3
Standard InChI Key: AREGOFXWITZLTL-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
7.7783 -14.5937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4904 -14.1864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1946 -14.5931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1946 -15.4126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4930 -15.8232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7783 -15.4178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4908 -13.3672 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7790 -12.9594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0710 -13.3666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0706 -14.1858 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3626 -14.5935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3626 -15.4130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6545 -15.8206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6545 -14.1858 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.1988 -12.9554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1988 -12.1401 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.9069 -13.3672 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.6150 -12.9554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
2 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
1 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
11 14 2 0
7 15 1 0
15 16 2 0
15 17 1 0
17 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 246.27 | Molecular Weight (Monoisotopic): 246.1004 | AlogP: 1.79 | #Rotatable Bonds: 1 |
Polar Surface Area: 49.85 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 1.38 | CX LogD: 1.38 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.71 | Np Likeness Score: -0.33 |
References
1. Sánchez-Martínez C, Lallena MJ, Sanfeliciano SG, de Dios A.. (2019) Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015-2019)., 29 (20): [PMID:31477350] [10.1016/j.bmcl.2019.126637] |